SCHEMBL1325399

SCHEMBL1325399

c1cn2sccc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11882764 0.59
SCHEMBL21352246 0.55 CDK8 (0.53)
SCHEMBL4952216 0.54
SCHEMBL5488201 0.54
SCHEMBL3962541 0.52 DYRK1A (0.41)
SCHEMBL31249062 0.52 ADORA3 (0.45)
SCHEMBL31237159 0.52 DYRK1A (0.41)
SCHEMBL174363 0.52
SCHEMBL173532 0.52
SCHEMBL63709 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228508-A1 TRICYCLIC FUSED THIOPHENE DERIVATIVES AS JAK INHIBITORS INCYTE CORPORATION 2024-07-11 US disclosed
US-20240228498-A1 TERTIARY ALCOHOLS AS PI3K-y INHIBITORS INCYTE CORPORATION 2024-07-11 US disclosed
US-12006320-B2 Heterocyclic derivatives as PI3K inhibitors INCYTE CORPORATION (US) 2024-06-11 US disclosed
EP-4352044-A1 MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES The General Hospital Corporation (US) 2024-04-17 EP disclosed
US-11926616-B2 Aminopyrazine diol compounds as PI3K-γ inhibitors INCYTE CORPORATION (US) 2024-03-12 US disclosed
US-11926630-B2 Tertiary alcohols as PI3K-γ inhibitors INCYTE CORPORATION (US) 2024-03-12 US disclosed
US-11912722-B2 Tricyclic heteroaryl compounds as sting activators INCYTE CORPORATION (US) 2024-02-27 US disclosed
WO-2022241470-A9 MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES THE GENERAL HOSPITAL CORPORATION (US) 2024-02-01 WO disclosed
US-11866432-B2 Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors INCYTE CORPORATION (US) 2024-01-09 US disclosed
US-20240002381-A1 1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS INCYTE CORPORATION 2024-01-04 US disclosed
US-20030023089-A1 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes AKHAVAN-TAFTI HASHEM (US) 2003-01-30 US disclosed
US-6296787-B1 ACRIDINE AND PHENANTHRIDINE ALKENYL PHOSPHATE DERIVATIVES LUMIGEN, INC. 2001-10-02 US disclosed
US-6270695-B1 HETEROCYCLIC COMPOUNDS WITH EXOCYCLIC DOUBLE BOND HAVING PHOSPHATE GROUP ATTACHED TO DISTAL CARBON; DETECTION SENSITIVITY LUMIGEN, INC. 2001-08-07 US disclosed
US-6218137-B1 SENSITIVE QUANTITATIVE ANALYSIS USING COMPOUND HAVING A HETEROCYCLIC RING SYSTEM BEARING AN EXOCYCLIC CARBON-CARBON DOUBLE BOND WHICH IS SUBSTITUTED AT DISTAL CARBON WITH PHOSPHATE GROUP AND OXYGEN OR SULFUR GROUP LUMIGEN, INC. 2001-04-17 US disclosed
US-6139782-A A CHEMILUMINESCENT CONTAINING A HETEROCYCLIC RING GROUP AND AN ENOL PHOSPHATE GROUP WHICH REACT WITH OXYGEN UPON REMOVAL OF PHOSPHATE GROUP WITH A PHOSPHATASE ENZYME TO PRODUCE AN ENOLATE WHICH REACTS WITH TO PRODUCE CHEMILUMINOESCENCE LUMIGEN, INC. (US) 2000-10-31 US disclosed
US-6045727-A NITROGEN CONTAINING HETEROCYCLIC RING SYSTEM BEARING AN EXOCYCLIC CARBON-CARBON DOUBLE BOND. THE DOUBLE BOND IS FURTHER SUBSTITUTED AT THE DISTAL CARBON WITH A PHOSPHATE GROUP AND AN OXYGEN OR SULFUR ATOM-CONTAINING GROUP. LUMIGEN, INC. (US) 2000-04-04 US disclosed
EP-0369362-B1 Substrate composition for alkaline phosphatase and method for assay using same BECTON DICKINSON CO (US) 1995-02-15 EP disclosed
US-5135847-A Levamisole as phosphatase inhibitor; immunoassay BECTON, DICKINSON AND COMPANY (US) 1992-08-04 US disclosed
US-5093231-A Levamisole BECTON, DICKINSON AND COMPANY (US) 1992-03-03 US disclosed
EP-0369362-A2 Substrate composition for alkaline phosphatase and method for assay using same Becton, Dickinson and Company (US) 1990-05-23 EP disclosed